Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sagittarius Life Science Corp. (3205) Financial Statements

Sagittarius Life Science Corp. Financial Overview

Sagittarius Life Science Corp.'s market cap is currently NT$3.01B. The company's EPS TTM is NT$-0.23; its P/E ratio is -195.33; and it has a dividend yield of 2.91%. Sagittarius Life Science Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 346.08MNT$ 467.75MNT$ 440.46MNT$ 529.07MNT$ 587.61M
Gross ProfitNT$ 57.71MNT$ 81.11MNT$ 71.48MNT$ 82.56MNT$ 100.54M
Operating IncomeNT$ -58.51MNT$ -61.56MNT$ -64.38MNT$ -76.27MNT$ -87.07M
EBITDANT$ -48.16MNT$ -34.72MNT$ -41.71MNT$ -55.40MNT$ -65.92M
Net IncomeNT$ -49.56MNT$ -48.53MNT$ -55.04MNT$ -74.20MNT$ -86.42M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 803.55MNT$ 160.90MNT$ 215.38MNT$ 269.72MNT$ 358.91M
Total AssetsNT$ 1.07BNT$ 519.83MNT$ 664.72MNT$ 579.12MNT$ 675.75M
Total DebtNT$ 385.00KNT$ 10.77MNT$ 13.32MNT$ 11.37MNT$ 24.00M
Net DebtNT$ -151.16MNT$ -73.03MNT$ -120.57MNT$ -178.11MNT$ -231.66M
Total LiabilitiesNT$ 26.91MNT$ 100.07MNT$ 137.82MNT$ 123.70MNT$ 144.03M
Stockholders' EquityNT$ 1.04BNT$ 408.35MNT$ 514.65MNT$ 441.79MNT$ 516.77M
Cash Flow
Free Cash FlowNT$ -36.45MNT$ -48.28MNT$ -71.38MNT$ -53.98MNT$ -37.61M
Operating Cash FlowNT$ -36.05MNT$ -44.48MNT$ -69.37MNT$ -52.89MNT$ -29.18M
Investing Cash FlowNT$ -558.62MNT$ 2.73MNT$ 22.45MNT$ -1.14MNT$ -104.82M
Financing Cash FlowNT$ 662.89MNT$ -9.89MNT$ -7.89MNT$ -13.16MNT$ -4.16M

Currency in TWD

Sagittarius Life Science Corp. Earnings and Revenue History

-400M0400M800M-32 %-24 %-16 %-8 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Sagittarius Life Science Corp. Liabilities to Assets

0400M800M1.2B0 %8 %16 %24 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Sagittarius Life Science Corp. Cash Flow

-750M-500M-250M0250M500M750M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Sagittarius Life Science Corp. Forecast EPS vs Actual EPS

-0.4-0.3-0.2-0.100.1Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >